Loading data
OVIDNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7.25 m USD | 566 k USD | 392 k USD | 1.5 m USD | 208.38 m USD |
| Research and development expense | 25.58 m USD | 36.77 m USD | 28.59 m USD | 24.62 m USD | 46.94 m USD |
| Operating profit | -42.44 m USD | -61.89 m USD | -59.28 m USD | -55.55 m USD | 124.21 m USD |
| Profit before tax | -17.41 m USD | -26.43 m USD | -52.34 m USD | -54.17 m USD | 124.16 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | 0 USD | 1.33 m USD |
| Net income (reported basis) | -17.4 m USD | -26.4 m USD | -52.3 m USD | -54.2 m USD | 122.8 m USD |
| Net income attributable to common shareholders | — | — | -52.34 m USD | -54.17 m USD | 119.84 m USD |
| Basic earnings per share | — | — | -0.74 USD/share | -0.77 USD/share | 1.78 USD/share |
| Diluted earnings per share | — | — | -0.74 USD/share | -0.77 USD/share | 1.76 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.